SCHEMBL3998288

SCHEMBL3998288

COC(=O)c1cc(Cl)c(NC(C)=O)cc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
SMN1; SMN2 Q16637 4/20 0.54
HTT P42858 1/20 0.50
HPGD P15428 6/20 0.47
GAA P10253 2/20 0.46
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA9 Q16790 3/20 0.45
CA12 O43570 2/20 0.45
CA7 P43166 2/20 0.45
CA14 Q9ULX7 2/20 0.45
PDK2 Q15119 1/20 0.45
PDK4 Q16654 1/20 0.45
AGER Q15109 1/20 0.44
KDM4E B2RXH2 3/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
NPY1R P25929 1/20 0.44
NPY2R P49146 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10782316 0.85 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2HPGDCA1CA2
SCHEMBL3658766 0.85 CA1 (0.47) ALDH1A1SMN1; SMN2HTTHPGDCA1
SCHEMBL29618392 0.84 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2HTTHPGDCA1
SCHEMBL15797599 0.84 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2HTTHPGDGAA
SCHEMBL31464258 0.83 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2HTTHPGDCA1
SCHEMBL7317043 0.83 PYGL (0.55) ALDH1A1SMN1; SMN2HTTHPGDCA1
SCHEMBL130152 0.83 HTT (0.72) ALDH1A1SMN1; SMN2HTTHPGDGAA
SCHEMBL3659229 0.82 CA1 (0.49) ALDH1A1SMN1; SMN2HTTHPGDGAA
SCHEMBL21003306 0.82 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2HTTHPGDGAA
Hydrochloric Acid SCHEMBL7413426 0.82 GAA (0.47) ALDH1A1SMN1; SMN2HTTHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114591278-A Preparation method of 4-acetamido-5-chloro-2, 3-dihydrobenzofuran-7-carboxylic acid methyl ester 鲁南制药集团股份有限公司 2022-06-07 CN claimed
CN-107337658-A A kind of synthetic method of the chloro- 2,3- Dihydrobenzofuranes -7- carboxylic acids of butanedioic acid prucalopride intermediate 4- amino -5- 沈阳药科大学 2017-11-10 CN claimed
CN-119241461-A Mosapride citrate impurity compound and preparation method thereof 吉林修正药业新药开发有限公司 2025-01-03 CN disclosed
CN-114437007-B Preparation method of prizepride intermediate 鲁南制药集团股份有限公司 2024-03-19 CN disclosed
CN-115745929-B Preparation method of prizepine succinate key intermediate 山东四环药业股份有限公司 2024-01-19 CN disclosed
CN-112920132-B Small-molecule non-nucleoside compound serving as immunomodulator 齐鲁师范学院 2023-08-15 CN disclosed
CN-115745929-A Preparation method of prankari succinate key intermediate 山东四环药业股份有限公司 2023-03-07 CN disclosed
CN-115745928-A Preparation method of prucalopride intermediate 山东新时代药业有限公司 2023-03-07 CN disclosed
CN-114591278-A Preparation method of 4-acetamido-5-chloro-2, 3-dihydrobenzofuran-7-carboxylic acid methyl ester 鲁南制药集团股份有限公司 2022-06-07 CN disclosed
CN-114591278-A Preparation method of 4-acetamido-5-chloro-2, 3-dihydrobenzofuran-7-carboxylic acid methyl ester 鲁南制药集团股份有限公司 2022-06-07 CN disclosed
CN-114437007-A Preparation method of prucalopride intermediate 鲁南制药集团股份有限公司 2022-05-06 CN disclosed
WO-1989010364-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-11-02 WO disclosed
EP-0339950-A2 Dibenzofurancarboxamides, their use as pharmaceutical agents, a composition containing the same, and a process for the preparation thereof RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-11-02 EP disclosed
US-4863921-A Dibenzofurancarboxamides and their pharmaceutical compositions and methods RORER PHARMACEUTICAL CORPORATION (US) 1989-09-05 US disclosed
US-4835172-A Novel benzamides, intermediates and process for the preparation and therapeutic use thereof SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) 1989-05-30 US disclosed
EP-0018830-B1 SPIROBENZOFURANONES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Takeda Chemical Industries, Ltd. (JP) 1983-06-08 EP disclosed
EP-0003084-B1 SPIROBENZOFURANONE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES Takeda Chemical Industries, Ltd. (JP) 1982-02-24 EP disclosed
US-4284644-A Spirobenzofuranone compounds TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1981-08-18 US disclosed
EP-0018830-A2 Spirobenzofuranones, their production and pharmaceutical compositions containing them Takeda Chemical Industries, Ltd. (JP) 1980-11-12 EP disclosed
EP-0003084-A1 Spirobenzofuranone compounds, processes for their preparation and their use as medicines Takeda Chemical Industries, Ltd. (JP) 1979-07-25 EP disclosed